Aurora Daljit Singh

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 44. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 44
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Neumora Therapeutics, Inc.See RemarksOption exercisenothing paid21,055 sharesAug 21, 2026Neumora Therapeutics, Inc.See Remarksnothing paidExercise · Aug 21Option exercise21,055Aug 21, 2026
Neumora Therapeutics, Inc.See RemarksOption exercisenothing paid20,553 sharesAug 21, 2026Neumora Therapeutics, Inc.See Remarksnothing paidExercise · Aug 21Option exercise20,553Aug 21, 2026
Neumora Therapeutics, Inc.See RemarksAwardnothing paid200,000 sharesAug 21, 2026Neumora Therapeutics, Inc.See Remarksnothing paidAward · Aug 21Award200,000Aug 21, 2026
Neumora Therapeutics, Inc.See RemarksOption exercisenothing paid21,685 sharesAug 21, 2026Neumora Therapeutics, Inc.See Remarksnothing paidExercise · Aug 21Option exercise21,685Aug 21, 2026
Neumora Therapeutics, Inc.See RemarksOption exercisenothing paid45,026 sharesAug 21, 2026Neumora Therapeutics, Inc.See Remarksnothing paidExercise · Aug 21Option exercise45,026Aug 21, 2026